May « 2014 « Science and Enterprise

Stress, Diet Apps Numerous but Offer Only Short Term Help

By Alan, on May 30th, 2014%

Kirsikka Kaipainen (VTT.fi)

30 May 2014. Online and mobile apps for stress management and healthy eating are numerous and gaining more users, but their impact appears to be short lived, according to an analysis by a researcher in Finland. Kirsikka Kaipainen, a research scientist at VTT Technical Research Centre in Espoo, Finland, published her . . . → Read More: Stress, Diet Apps Numerous but Offer Only Short Term Help

Epigenetics Biotech Secures $12.9 Million Early Financing

By Alan, on May 30th, 2014%

(M4D Group/Flickr)

30 May 2014. Rodin Therapeutics Inc., a biotechnology company in Boston developing therapies based on epigenetics — inherited changes in genetic activity outside of DNA — raised $12.9 million in its first venture funding round. The company is a joint venture of Proteros biostructures GmbH in Munich and Atlas Ventures in . . . → Read More: Epigenetics Biotech Secures $12.9 Million Early Financing

More Efficient Growth Factor Delivery Technique Devised

By Alan, on May 29th, 2014%

Todd McDevitt (Georgia Institute of Technology)

29 May 2014. Biologists and engineers at Georgia Institute of Technology in Atlanta developed a new process that delivers tissue-building proteins used in regenerative medicine known as growth factors in much higher concentrations than current methods. The team led by Georgia Tech bioengineering professor Todd McDevitt published . . . → Read More: More Efficient Growth Factor Delivery Technique Devised

Remote Heart Failure Monitoring Device Approved by FDA

By Alan, on May 29th, 2014%

CardioMEMS pulmonary artery sensor (St. Jude Medical Inc.)

29 May 2014. The U.S. Food and Drug Administration yesterday approved an implanted device that measures pulmonary artery pressure and heart rate of patients with moderate heart failure who were hospitalized in the previous year. The device, the CardioMEMS HF System, is made by CardioMEMS . . . → Read More: Remote Heart Failure Monitoring Device Approved by FDA

Ohio State, Cancer Center Partner on Research Database

By Alan, on May 28th, 2014%

(HealthIT.gov)

28 May 2014. Moffitt Cancer Center in Tampa and Ohio State University’s Comprehensive Cancer Center in Columbus are launching a repository of patient data and tumor samples to speed development of therapies and better match patients to clinical trials. Financial details of the Oncology Research Information Exchange Network or Orien created by . . . → Read More: Ohio State, Cancer Center Partner on Research Database

Medical Centers to Develop Brain Signal Tracking, Therapies

By Alan, on May 28th, 2014%

(DARPA.mil)

28 May 2014. Massachusetts General Hospital in Boston and University of California in San Francisco are developing technologies to analyze brain activity and deliver near real-time neural stimulation therapies. The five-year project is funded by grants from Defense Advanced Research Projects Agency (DARPA) of $30 million and $26 million respectively to Mass. . . . → Read More: Medical Centers to Develop Brain Signal Tracking, Therapies

Five Pharma Companies to Share Clinical Researcher Data

By Alan, on May 27th, 2014%

(waferboard/Flickr)

27 May 2014. Five pharmaceutical companies are joining together to share their files on researchers conducting clinical trials, to speed the administrative process of starting up new studies. The Investigator Databank is a joint project of Novartis, Janssen (a division of Johnson & Johnson), Merck, Eli Lilly and Co., and Pfizer, and . . . → Read More: Five Pharma Companies to Share Clinical Researcher Data

Drug Sensitivity Target Identified for Mesothelioma Therapy

By Alan, on May 27th, 2014%

(National Cancer Institute)

27 May 2014. Researchers at the biopharmaceutical company Verastem Inc. in Cambridge, Massachusetts found the loss of a certain tumor suppressor improves responsiveness to therapies targeting cancer stem cells that treat mesothelioma, an aggressive form of lung cancer. The team led by Verastem’s research director Jonathan Pachter, with colleagues from . . . → Read More: Drug Sensitivity Target Identified for Mesothelioma Therapy

Memorial Day 2014

By Alan, on May 26th, 2014%

Vietnam War Memorial, Washington, D.C. (A. Kotok)

26 May 2014. Today is Memorial Day in the U.S., and Science & Enterprise is observing the holiday. We will return to our regular postings tomorrow.

* * *

Industrial Scale Graphene Production Process Devised

By Alan, on May 23rd, 2014%

Graphene molecular illustration (Lawrence Berkeley National Laboratory)

23 May 2014. Engineers at University of Michigan, Massachusetts Institute of Technology, and glass manufacturer Guardian Industries developed a process for producing graphene that overcomes many of the obstacles preventing industrial-scale production of this material. The findings of a research team led by MIT’s John Hart . . . → Read More: Industrial Scale Graphene Production Process Devised

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise